COVID-19 convalescent plasma and randomized clinical trials: explaining conflicting outcomes and finding signals of efficacy
View ORCID ProfileDaniele Focosi, View ORCID ProfileMassimo Franchini, View ORCID ProfileLiise-anne Pirofski, View ORCID ProfileThierry Burnouf, View ORCID ProfileNigel Paneth, View ORCID ProfileMichael J. Joyner, View ORCID ProfileArturo Casadevall
doi: https://doi.org/10.1101/2021.09.07.21263194
Daniele Focosi
1North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy.
Massimo Franchini
2Division of Transfusion Medicine, Carlo Poma Hospital, 46100 Mantua, Italy;
Liise-anne Pirofski
3Division of Infectious Diseases, Albert Einstein College of Medicine and Montefiore Medical Center, New York, NY 10467, USA;
Thierry Burnouf
4Graduate Institute of Biomedical Materials and Tissue Engineering & International PhD Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan;
Nigel Paneth
5Departments of Epidemiology & Biostatistics and Pediatrics & Human Development, College of Human Medicine, Michigan State University, East Lansing, MI 48824,
Michael J. Joyner
6Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA;
Arturo Casadevall
7Department of Medicine, Johns Hopkins School of Public Health and School of Medicine, Baltimore, MD, USA;

Data Availability
All data are available via request to the corresponding author
Posted December 27, 2021.
COVID-19 convalescent plasma and randomized clinical trials: explaining conflicting outcomes and finding signals of efficacy
Daniele Focosi, Massimo Franchini, Liise-anne Pirofski, Thierry Burnouf, Nigel Paneth, Michael J. Joyner, Arturo Casadevall
medRxiv 2021.09.07.21263194; doi: https://doi.org/10.1101/2021.09.07.21263194
COVID-19 convalescent plasma and randomized clinical trials: explaining conflicting outcomes and finding signals of efficacy
Daniele Focosi, Massimo Franchini, Liise-anne Pirofski, Thierry Burnouf, Nigel Paneth, Michael J. Joyner, Arturo Casadevall
medRxiv 2021.09.07.21263194; doi: https://doi.org/10.1101/2021.09.07.21263194
Subject Area
Subject Areas
- Addiction Medicine (410)
- Allergy and Immunology (725)
- Anesthesia (214)
- Cardiovascular Medicine (3085)
- Dermatology (260)
- Emergency Medicine (462)
- Epidemiology (13014)
- Forensic Medicine (13)
- Gastroenterology (860)
- Genetic and Genomic Medicine (4833)
- Geriatric Medicine (445)
- Health Economics (750)
- Health Informatics (3054)
- Health Policy (1101)
- Hematology (407)
- HIV/AIDS (956)
- Medical Education (453)
- Medical Ethics (119)
- Nephrology (499)
- Neurology (4602)
- Nursing (244)
- Nutrition (683)
- Oncology (2385)
- Ophthalmology (673)
- Orthopedics (268)
- Otolaryngology (333)
- Pain Medicine (300)
- Palliative Medicine (87)
- Pathology (514)
- Pediatrics (1238)
- Primary Care Research (519)
- Public and Global Health (7186)
- Radiology and Imaging (1601)
- Respiratory Medicine (943)
- Rheumatology (459)
- Sports Medicine (403)
- Surgery (509)
- Toxicology (65)
- Transplantation (220)
- Urology (189)